Pub Date : 2026-02-01Epub Date: 2025-12-11DOI: 10.1016/j.smrv.2025.102225
Yansu He , Shuting Wang , Tianhang Zhang , Yuxuan Gu , Zuyao Yang , Linying Wu , Kin Fai Ho
The contribution of air pollution to obstructive sleep apnea (OSA) remains unclear. This systematic review and meta-analysis evaluated the impact of air pollution across different exposure windows on OSA and examined effect modifiers. Pubmed, Web of Science, and Embase were searched from inception to September 2024. Meta-analyses synthesized risk estimates using fixed- or random-effects models with I2 heterogeneity assessment. Certainty of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. Of 5196 potential papers, 20 studies were included, with 13 eligible for meta-analysis. High-certainty evidence indicated that each 10 μg/m3 increase in short- and long-term PM2.5 exposure was associated with a 2.25 % (95 % CI: 1.10 to 3.41) and 13.33 % (95 % CI: 9.85 to 16.80) increase in apnea-hypopnea index (AHI), respectively. For NO2, each 10 ppb increase in short- and long-term exposure was associated with a 2.92 % (95 % CI: 1.29 to 4.54) and 8.93 % (95 % CI: 2.06 to 15.79) increase in AHI, with high- and moderate-certainty evidence, respectively. Medium-term PM2.5 and NO2 exposure were also associated with AHI, although with low certainty. No significant associations were observed for PM10 and O3. Exposure to PM2.5 and NO2, but not PM10 or O3, was associated with OSA severity.
空气污染对阻塞性睡眠呼吸暂停(OSA)的影响尚不清楚。本系统综述和荟萃分析评估了不同暴露窗口的空气污染对OSA的影响,并检查了影响调节剂。Pubmed, Web of Science和Embase从成立到2024年9月进行了搜索。荟萃分析使用固定或随机效应模型综合风险估计,并进行I2异质性评估。证据的确定性采用GRADE(建议评估、发展和评价分级)方法进行评估。在5196篇潜在论文中,纳入了20篇研究,其中13篇符合meta分析的条件。高确定性证据表明,短期和长期PM2.5暴露每增加10 μg/m3,呼吸暂停低通气指数(AHI)分别增加2.25% (95% CI: 1.10至3.41)和13.33% (95% CI: 9.85至16.80)。对于二氧化氮,短期和长期暴露每增加10 ppb, AHI分别增加2.92% (95% CI: 1.29至4.54)和8.93% (95% CI: 2.06至15.79),具有高确定性和中等确定性的证据。中期PM2.5和NO2暴露也与AHI相关,尽管确定性较低。PM10和O3没有明显的相关性。暴露于PM2.5和NO2,而不是PM10或O3,与OSA严重程度相关。
{"title":"Does short- and long-term exposure to air pollution affect the risk of obstructive sleep apnea? A systematic review and meta-analysis","authors":"Yansu He , Shuting Wang , Tianhang Zhang , Yuxuan Gu , Zuyao Yang , Linying Wu , Kin Fai Ho","doi":"10.1016/j.smrv.2025.102225","DOIUrl":"10.1016/j.smrv.2025.102225","url":null,"abstract":"<div><div>The contribution of air pollution to obstructive sleep apnea (OSA) remains unclear. This systematic review and meta-analysis evaluated the impact of air pollution across different exposure windows on OSA and examined effect modifiers. Pubmed, Web of Science, and Embase were searched from inception to September 2024. Meta-analyses synthesized risk estimates using fixed- or random-effects models with I<sup>2</sup> heterogeneity assessment. Certainty of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. Of 5196 potential papers, 20 studies were included, with 13 eligible for meta-analysis. High-certainty evidence indicated that each 10 μg/m<sup>3</sup> increase in short- and long-term PM<sub>2.5</sub> exposure was associated with a 2.25 % (95 % CI: 1.10 to 3.41) and 13.33 % (95 % CI: 9.85 to 16.80) increase in apnea-hypopnea index (AHI), respectively. For NO<sub>2</sub>, each 10 ppb increase in short- and long-term exposure was associated with a 2.92 % (95 % CI: 1.29 to 4.54) and 8.93 % (95 % CI: 2.06 to 15.79) increase in AHI, with high- and moderate-certainty evidence, respectively. Medium-term PM<sub>2.5</sub> and NO<sub>2</sub> exposure were also associated with AHI, although with low certainty. No significant associations were observed for PM<sub>10</sub> and O<sub>3</sub>. Exposure to PM<sub>2.5</sub> and NO<sub>2</sub>, but not PM<sub>10</sub> or O<sub>3</sub>, was associated with OSA severity.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102225"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Obstructive sleep apnea is under-diagnosed, under-reported and therefore under-treated in patients after a stroke. The aim of this meta-analysis of Randomized Control Trials (RCTs) was to investigate the effectiveness of positive airway treatment on recurrent vascular events, neurological deficit, functional independence, depression, sleepiness and cognitive function in patients post-stroke.
Records identified from Embase Elsevier Database (Embase, Medline/PubMed, Preprints, PubMed-not-Medline) were searched from inception in July 2024, up to September 2024. After screening 72387 records, 21 RCTs were included with 1457 patients with stroke. Out of these 753 patients were in the PAP arm and 704 in the conventional arm.
Metanalysis showed that PAP treatment reduced recurrent vascular events OR 0.45, (95 % Confidence Interval (CI) 0.28 to 0.78; p < 0.01), improved neurological deficit OR -0.30, (95 % CI -0.47 to −0.14; p < 0.01), reduced daytime sleepiness OR: −0.96, (95 % CI -1.47 to −0.45; p < 0.01), improved depression levels; OR: −0.58, (95 % CI -1.05 to −0.11; p = 0.02), improved cognitive function; OR1.10; (95 % CI 0.35 to 1.86; p = 0.02), but did not improve functional independence OR 0.25, (95 % CI -0.11 to 0.60; p = 0.17)
Therefore, positive airway pressure treatment is effective in patients with stroke and can reduce recurrent vascular events and improve recovery of these patients.
阻塞性睡眠呼吸暂停在中风后的患者中诊断、报告不足,因此治疗不足。这项随机对照试验(RCTs)的荟萃分析的目的是研究正气道治疗对卒中后血管事件复发、神经功能缺损、功能独立、抑郁、嗜睡和认知功能的有效性。从Embase爱思唯尔数据库(Embase, Medline/PubMed, Preprints, PubMed-not-Medline)中识别的记录从2024年7月到2024年9月进行检索。在筛选72387份记录后,纳入21项随机对照试验,纳入1457例脑卒中患者。其中753名患者在PAP组,704名患者在常规组。荟萃分析显示PAP治疗减少血管复发事件OR 0.45,(95%可信区间(CI) 0.28 ~ 0.78;p < 0.01),改善神经功能缺损OR -0.30, (95% CI -0.47至- 0.14;p < 0.01),减少白天嗜睡OR: - 0.96, (95% CI -1.47至- 0.45;p < 0.01),改善抑郁水平;OR: - 0.58, (95% CI -1.05 ~ - 0.11; p = 0.02),认知功能改善;OR1.10;(95% CI 0.35 ~ 1.86; p = 0.02),但未改善功能独立性OR 0.25, (95% CI -0.11 ~ 0.60; p = 0.17)因此,气道正压治疗对脑卒中患者有效,可减少血管事件复发,提高患者康复。
{"title":"Post-stroke sleep disordered breathing and the effect of positive airway pressure treatment: An updated systematic review and meta-analysis of randomized control trials","authors":"Fotios Sampsonas , Vasileios Karamouzos , Michael Doulberis , Kyriakos Karkoulias , Dimosthenis Lykouras , Paschalis Steiropoulos , Argyrios Tzouvelekis","doi":"10.1016/j.smrv.2025.102207","DOIUrl":"10.1016/j.smrv.2025.102207","url":null,"abstract":"<div><div>Obstructive sleep apnea is under-diagnosed, under-reported and therefore under-treated in patients after a stroke. The aim of this meta-analysis of Randomized Control Trials (RCTs) was to investigate the effectiveness of positive airway treatment on recurrent vascular events, neurological deficit, functional independence, depression, sleepiness and cognitive function in patients post-stroke.</div><div>Records identified from Embase Elsevier Database (Embase, Medline/PubMed, Preprints, PubMed-not-Medline) were searched from inception in July 2024, up to September 2024. After screening 72387 records, 21 RCTs were included with 1457 patients with stroke. Out of these 753 patients were in the PAP arm and 704 in the conventional arm.</div><div>Metanalysis showed that PAP treatment reduced recurrent vascular events OR 0.45, (95 % Confidence Interval (CI) 0.28 to 0.78; p < 0.01), improved neurological deficit OR -0.30, (95 % CI -0.47 to −0.14; p < 0.01), reduced daytime sleepiness OR: −0.96, (95 % CI -1.47 to −0.45; p < 0.01), improved depression levels; OR: −0.58, (95 % CI -1.05 to −0.11; p = 0.02), improved cognitive function; OR1.10; (95 % CI 0.35 to 1.86; p = 0.02), but did not improve functional independence OR 0.25, (95 % CI -0.11 to 0.60; p = 0.17)</div><div>Therefore, positive airway pressure treatment is effective in patients with stroke and can reduce recurrent vascular events and improve recovery of these patients.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102207"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145584159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-12-11DOI: 10.1016/j.smrv.2025.102224
Lorenz Grolig , Hanna Brückner , Hannah Heimes , Claudia Buntrock , Christin Hempeler , Kai Spiegelhalder , Dirk Lehr
The Declaration of Helsinki (DoH) provides guidance on the choice of comparators in clinical trials, stating that new treatments must be compared against the best proven treatment. This systematic review examines whether research on a new treatment – internet-delivered cognitive behavioral therapy for insomnia (iCBT-I) – has adhered to these DoH requirements. A systematic literature search for randomized controlled trials (RCTs) testing iCBT-I in clinical samples was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. To identify the gold standard treatment, national guidelines were analyzed for all countries where published research on iCBT-I had been conducted.
After screening, 32 RCTs and seven guidelines for 12 countries were included. Almost all guidelines recommend face-to-face CBT-I as the gold standard, but only four (12.5 %) of the RCTs used this gold standard as a comparator. None of the other trials explained why they did not follow the DoH's recommendation.
The majority of clinical trials did not compare iCBT-I against the gold standard. As the DoH is intended to guide clinical research ethics, this low level of adherence is remarkable, and it raises uncertainty for patients, therapists, and policymakers about the effectiveness of iCBT-I compared to the gold standard treatment.
{"title":"Time to take the Declaration of Helsinki seriously? A systematic review of comparison conditions in clinical trials on internet-delivered cognitive behavioral therapy for insomnia","authors":"Lorenz Grolig , Hanna Brückner , Hannah Heimes , Claudia Buntrock , Christin Hempeler , Kai Spiegelhalder , Dirk Lehr","doi":"10.1016/j.smrv.2025.102224","DOIUrl":"10.1016/j.smrv.2025.102224","url":null,"abstract":"<div><div>The Declaration of Helsinki (DoH) provides guidance on the choice of comparators in clinical trials, stating that new treatments must be compared against the best proven treatment. This systematic review examines whether research on a new treatment – internet-delivered cognitive behavioral therapy for insomnia (iCBT-I) – has adhered to these DoH requirements. A systematic literature search for randomized controlled trials (RCTs) testing iCBT-I in clinical samples was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. To identify the gold standard treatment, national guidelines were analyzed for all countries where published research on iCBT-I had been conducted.</div><div>After screening, 32 RCTs and seven guidelines for 12 countries were included. Almost all guidelines recommend face-to-face CBT-I as the gold standard, but only four (12.5 %) of the RCTs used this gold standard as a comparator. None of the other trials explained why they did not follow the DoH's recommendation.</div><div>The majority of clinical trials did not compare iCBT-I against the gold standard. As the DoH is intended to guide clinical research ethics, this low level of adherence is remarkable, and it raises uncertainty for patients, therapists, and policymakers about the effectiveness of iCBT-I compared to the gold standard treatment.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102224"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145737280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-21DOI: 10.1016/j.smrv.2026.102234
Christopher B. Miller , Ian Wood , Colin A. Espie
{"title":"Letter to the editor: Higher risk evidence underlying claims of therapist-delivered CBT-I superiority","authors":"Christopher B. Miller , Ian Wood , Colin A. Espie","doi":"10.1016/j.smrv.2026.102234","DOIUrl":"10.1016/j.smrv.2026.102234","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102234"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-13DOI: 10.1016/j.smrv.2026.102235
Eirini Pagkalidou , Christos K. Papagiannopoulos , Maria Manou , Panagiotis Filis , Rebecca C. Richmond , Konstantinos K. Tsilidis , Georgios Markozannes , Christos V. Chalitsios
Sleep traits (duration, insomnia, chronotype, snoring) are modifiable lifestyle factors that may influence cancer risk, but their association with reproductive cancers remains unclear. We systematically searched PubMed, Scopus, and Web of Science (until 09/2024) for observational studies investigating associations between sleep traits and reproductive cancers (including breast, prostate, endometrial, epithelial ovarian). We extracted estimates from maximally adjusted models and performed random-effects and dose-response meta-analyses. This study included 62 observational studies (45 cohort, 17 case-control) from 55 publications, but cohorts were primarily considered in interpretation. Compared to a morning chronotype, evening chronotype was associated with higher risk of breast cancer (HR = 1.12; 95 %CI: 1.07–1.17; I2 = 14 %; 4 cohorts) and epithelial ovarian cancer (HR = 1.15; 95 %CI: 1.02–1.29; I2 = 0 %; 2 cohorts). Insomnia was associated with elevated breast cancer risk (RR = 1.23; 95 %CI: 1.01–1.50; I2 = 94 %; 9 cohorts), and the association remained similar for diagnosed insomnia (RR = 1.26; 95 %CI: 1.01–1.58; I2 = 96 %; 5 studies), but high between-study heterogeneity was observed and the association was lost in properly adjusted studies (RR = 1.04; 95 %CI: 0.95–1.14; I2 = 41.5 %; 3 cohorts). These findings support a role for circadian disruption in carcinogenesis. Future research should use objective sleep assessments and evaluate whether modifying sleep behaviours or circadian alignment can reduce cancer risk.
{"title":"Unravelling the association between sleep traits and reproductive cancers: A systematic review and meta-analysis","authors":"Eirini Pagkalidou , Christos K. Papagiannopoulos , Maria Manou , Panagiotis Filis , Rebecca C. Richmond , Konstantinos K. Tsilidis , Georgios Markozannes , Christos V. Chalitsios","doi":"10.1016/j.smrv.2026.102235","DOIUrl":"10.1016/j.smrv.2026.102235","url":null,"abstract":"<div><div>Sleep traits (duration, insomnia, chronotype, snoring) are modifiable lifestyle factors that may influence cancer risk, but their association with reproductive cancers remains unclear. We systematically searched PubMed, Scopus, and Web of Science (until 09/2024) for observational studies investigating associations between sleep traits and reproductive cancers (including breast, prostate, endometrial, epithelial ovarian). We extracted estimates from maximally adjusted models and performed random-effects and dose-response meta-analyses. This study included 62 observational studies (45 cohort, 17 case-control) from 55 publications, but cohorts were primarily considered in interpretation. Compared to a morning chronotype, evening chronotype was associated with higher risk of breast cancer (HR = 1.12; 95 %CI: 1.07–1.17; I<sup>2</sup> = 14 %; 4 cohorts) and epithelial ovarian cancer (HR = 1.15; 95 %CI: 1.02–1.29; I<sup>2</sup> = 0 %; 2 cohorts). Insomnia was associated with elevated breast cancer risk (RR = 1.23; 95 %CI: 1.01–1.50; I<sup>2</sup> = 94 %; 9 cohorts), and the association remained similar for diagnosed insomnia (RR = 1.26; 95 %CI: 1.01–1.58; I<sup>2</sup> = 96 %; 5 studies), but high between-study heterogeneity was observed and the association was lost in properly adjusted studies (RR = 1.04; 95 %CI: 0.95–1.14; I<sup>2</sup> = 41.5 %; 3 cohorts). These findings support a role for circadian disruption in carcinogenesis. Future research should use objective sleep assessments and evaluate whether modifying sleep behaviours or circadian alignment can reduce cancer risk.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102235"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146012980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-15DOI: 10.1016/j.smrv.2026.102233
Meng-Yi Chen , Hua-Qing Xing , Qian-Hua Huang , Yuan Feng , Qinge Zhang , Ping Fan , Han-Xi Chen , Matteo Malgaroli , Todd Jackson , Gang Wang , Yu-Tao Xiang
Background
Given the increased use of network analysis in sleep studies, this systematic review and statistical evaluation aimed to aggregate network studies to identify the most central symptoms in composite network models of sleep-related symptoms.
Methods
A systematic search of cross-sectional network studies focused exclusively on sleep within community or clinical samples was conducted across PubMed, Web of Science (WOS), PsycINFO, and EMBASE databases up to March 5, 2025. Studies were categorized by topic and measurement instruments. Statistical evaluations extracted the most central symptoms across network models.
Results
The review included 23 studies of 84,510 participants and 29 network models. Explored topics included insomnia/sleep disturbances, sleep quality, sleep attitudes and behaviors, daytime function, and dream content. Regarding main analyses, key central symptoms in network models of insomnia were “Difficulty staying asleep” [median rank:1.5, Interquartile range (IQR): 1–2], “Distress caused by the sleep difficulties” (median rank:2, IQR: 2–3) and “Interference with daytime functioning” (median rank:3.5, IQR: 2.25–4). For sleep quality, “Subjective sleep quality” (median rank:1, IQR: 1-1), “Daytime dysfunction” (median rank:3, IQR: 2–5.25) and “Sleep disturbance” (median rank:3.5, IQR: 2–4.5) were the most central experiences.
Conclusions
Identified central symptoms offer plausible targets for intervention across populations and guide future research directions.
{"title":"Network models of subjective sleep health: a systematic review and statistical evaluation","authors":"Meng-Yi Chen , Hua-Qing Xing , Qian-Hua Huang , Yuan Feng , Qinge Zhang , Ping Fan , Han-Xi Chen , Matteo Malgaroli , Todd Jackson , Gang Wang , Yu-Tao Xiang","doi":"10.1016/j.smrv.2026.102233","DOIUrl":"10.1016/j.smrv.2026.102233","url":null,"abstract":"<div><h3>Background</h3><div>Given the increased use of network analysis in sleep studies, this systematic review and statistical evaluation aimed to aggregate network studies to identify the most central symptoms in composite network models of sleep-related symptoms.</div></div><div><h3>Methods</h3><div>A systematic search of cross-sectional network studies focused exclusively on sleep within community or clinical samples was conducted across PubMed, Web of Science (WOS), PsycINFO, and EMBASE databases up to March 5, 2025. Studies were categorized by topic and measurement instruments. Statistical evaluations extracted the most central symptoms across network models.</div></div><div><h3>Results</h3><div>The review included 23 studies of 84,510 participants and 29 network models. Explored topics included insomnia/sleep disturbances, sleep quality, sleep attitudes and behaviors, daytime function, and dream content. Regarding main analyses, key central symptoms in network models of insomnia were “Difficulty staying asleep” [median rank:1.5, Interquartile range (IQR): 1–2], “Distress caused by the sleep difficulties” (median rank:2, IQR: 2–3) and “Interference with daytime functioning” (median rank:3.5, IQR: 2.25–4). For sleep quality, “Subjective sleep quality” (median rank:1, IQR: 1-1), “Daytime dysfunction” (median rank:3, IQR: 2–5.25) and “Sleep disturbance” (median rank:3.5, IQR: 2–4.5) were the most central experiences.</div></div><div><h3>Conclusions</h3><div>Identified central symptoms offer plausible targets for intervention across populations and guide future research directions.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102233"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-20DOI: 10.1016/j.smrv.2026.102238
Monica Levy Andersen PhD (Editor in Chief of Sleep Medicine Reviews)
{"title":"Beyond the pulse and the pressure: human intelligence in the age of algorithmic Sleep Medicine","authors":"Monica Levy Andersen PhD (Editor in Chief of Sleep Medicine Reviews)","doi":"10.1016/j.smrv.2026.102238","DOIUrl":"10.1016/j.smrv.2026.102238","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102238"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-22DOI: 10.1016/j.smrv.2025.102206
Morgan J. Thompson , Alexandra D. Ehrhardt , Ekjyot K. Saini , Emily F. Brigham , Zeynep Su Altinoz , Tiffany Yip , Joseph A. Buckhalt , Mona El-Sheikh
Children and adolescents from racial and ethnic minority and socioeconomically disadvantaged backgrounds are at greater risk for health disparities. This meta-analysis examined the association between sleep and mental health, with attention to variations by: (a) race, ethnicity, and socioeconomic status, and (b) individual sleep parameters and mental health domains. The review included 104 studies (66 independent samples, 326,478 participants). Less optimal sleep was associated with worse mental health (r = −.20, 95% CI [–.23, −.16]). Subjective sleep quality was a stronger correlate of mental health relative to all other sleep parameters (bs ranged from .11 to .19, ps < .001). Sleep schedule was a stronger correlate than objective sleep duration and quality (bs = .08 and .07, respectively, ps < .01). Sleep consistency was also a stronger correlate than objective sleep duration (b = .05, p = .03). Socioeconomic status moderated two associations. Objective sleep quality was more strongly linked to mental health among middle- relative to mixed-SES samples (b = .11, p = .01). Sleep consistency was more strongly associated with mental health among low- compared to mixed-SES samples (b = .05, p = .002). Findings are discussed in the context of methodological challenges in studying health disparities.
来自种族和族裔少数群体和社会经济不利背景的儿童和青少年面临更大的健康差异风险。这项荟萃分析考察了睡眠和心理健康之间的关系,并注意到:(a)种族、民族和社会经济地位的差异,以及(b)个体睡眠参数和心理健康领域的差异。该综述包括104项研究(66个独立样本,326,478名参与者)。较差的最佳睡眠与较差的心理健康相关(r = -)。20, 95% ci[-]。23日,−16])。相对于所有其他睡眠参数,主观睡眠质量与心理健康的相关性更强。11 . to…19, ps < .001)。睡眠计划与客观睡眠时间和质量的相关性更强(bs = .08和。分别为(p < .01)。睡眠一致性也比客观睡眠时间更强(b = 0.05, p = 0.03)。社会经济地位调节了这两种关联。目的:相对于混合ses样本,中等ses样本的睡眠质量与心理健康的关系更强(b = .11, p = .01)。与混合ses相比,低ses样本的睡眠一致性与心理健康的关系更强(b = 0.05, p = 0.002)。在研究健康差异的方法挑战的背景下讨论了研究结果。
{"title":"Unpacking sleep and mental health disparities across childhood and adolescence: A meta-analytic and systematic review","authors":"Morgan J. Thompson , Alexandra D. Ehrhardt , Ekjyot K. Saini , Emily F. Brigham , Zeynep Su Altinoz , Tiffany Yip , Joseph A. Buckhalt , Mona El-Sheikh","doi":"10.1016/j.smrv.2025.102206","DOIUrl":"10.1016/j.smrv.2025.102206","url":null,"abstract":"<div><div>Children and adolescents from racial and ethnic minority and socioeconomically disadvantaged backgrounds are at greater risk for health disparities. This meta-analysis examined the association between sleep and mental health, with attention to variations by: (a) race, ethnicity, and socioeconomic status, and (b) individual sleep parameters and mental health domains. The review included 104 studies (66 independent samples, 326,478 participants). Less optimal sleep was associated with worse mental health (<em>r</em> = −.20, 95% CI [–.23, −.16]). Subjective sleep quality was a stronger correlate of mental health relative to all other sleep parameters (<em>b</em>s ranged from .11 to .19, <em>p</em>s < .001). Sleep schedule was a stronger correlate than objective sleep duration and quality (<em>b</em>s = .08 and .07, respectively, <em>p</em>s < .01). Sleep consistency was also a stronger correlate than objective sleep duration (<em>b</em> = .05, <em>p</em> = .03). Socioeconomic status moderated two associations. Objective sleep quality was more strongly linked to mental health among middle- relative to mixed-SES samples (<em>b</em> = .11, <em>p</em> = .01). Sleep consistency was more strongly associated with mental health among low- compared to mixed-SES samples (<em>b</em> = .05, <em>p</em> = .002). Findings are discussed in the context of methodological challenges in studying health disparities.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102206"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-13DOI: 10.1016/j.smrv.2026.102229
Wan-Qi Zhang , Xiao-Lin Li , Rui-Peng Xu , Yu-Long Li , Peng-Fei Hu , Ka-Hing Wong , Zhong-Yang Lin , Qiong-Qiong Yang , Bo-Bo Zhang
Sleep disorders affect approximately 27 % of the global population, driving non-pharmacological research on gut-brain axis regulation. Understanding sleep mechanisms is crucial, given its profound impact on health and disease. Caenorhabditis elegans (C. elegans) offers a powerful model for dissecting fundamental sleep processes, owing to its compact and fully mapped nervous system, genetic tractability, and suitability for high-throughput screening. This review leverages C. elegans integrated with gene editing, high-throughput behavioral phenotyping, and calcium imaging to dissect gut microbiota's role in sleep modulation. We explore how microbial metabolites regulate sleep via gut-brain pathways and summarize conserved sleep-related molecular mechanisms. The purpose of this review is to decode gut-brain-sleep axis interactions, offering novel mechanistic insights into sleep disorder pathophysiology.
{"title":"Advances in sleep research based on the Caenorhabditis elegans: an intestinal microbiota perspective and cutting-edge technology applications","authors":"Wan-Qi Zhang , Xiao-Lin Li , Rui-Peng Xu , Yu-Long Li , Peng-Fei Hu , Ka-Hing Wong , Zhong-Yang Lin , Qiong-Qiong Yang , Bo-Bo Zhang","doi":"10.1016/j.smrv.2026.102229","DOIUrl":"10.1016/j.smrv.2026.102229","url":null,"abstract":"<div><div>Sleep disorders affect approximately 27 % of the global population, driving non-pharmacological research on gut-brain axis regulation. Understanding sleep mechanisms is crucial, given its profound impact on health and disease. <em>Caenorhabditis elegans</em> (<em>C. elegans</em>) offers a powerful model for dissecting fundamental sleep processes, owing to its compact and fully mapped nervous system, genetic tractability, and suitability for high-throughput screening. This review leverages <em>C. elegans</em> integrated with gene editing, high-throughput behavioral phenotyping, and calcium imaging to dissect gut microbiota's role in sleep modulation. We explore how microbial metabolites regulate sleep via gut-brain pathways and summarize conserved sleep-related molecular mechanisms. The purpose of this review is to decode gut-brain-sleep axis interactions, offering novel mechanistic insights into sleep disorder pathophysiology.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102229"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146037460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This systematic review provides an overview of the use of medical hypnosis for non-rapid eye movement parasomnias. It aims to describe the hypnotic inductions and suggestions applied in this context and assess their reported effectiveness. From a total of 427 articles identified through a comprehensive search of major medical databases, 24 studies met inclusion criteria. The majority were individual case reports or small case series, with only one study using a controlled design. Across these studies, 348 individuals with non-rapid eye movement parasomnias were described, with 148 receiving treatments with hypnosis. A positive clinical response was reported in approximately 82.6 % of these treated cases. However, the overall quality of evidence was low, with most studies offering limited methodological robustness and lacking standardized outcome measures. The hypnotic induction and suggestion techniques varied widely, yet general suggestions aimed at improving sleep quality were more frequently reported than specific ones targeting parasomnia features. Nevertheless, the more specific suggestions seemed to have better outcomes. This review suggests that hypnosis could be a promising therapeutic option. However, further, well-designed trials are required, including objective outcome evaluation, and standardized, targeted hypnotic approaches developed collaboratively between sleep and hypnosis specialists.
{"title":"Hypnosis as therapy for non-REM parasomnia: A literature review","authors":"Geoffroy Solelhac , Nina Rimorini , Chantal Berna , Francesca Siclari","doi":"10.1016/j.smrv.2025.102227","DOIUrl":"10.1016/j.smrv.2025.102227","url":null,"abstract":"<div><div>This systematic review provides an overview of the use of medical hypnosis for non-rapid eye movement parasomnias. It aims to describe the hypnotic inductions and suggestions applied in this context and assess their reported effectiveness. From a total of 427 articles identified through a comprehensive search of major medical databases, 24 studies met inclusion criteria. The majority were individual case reports or small case series, with only one study using a controlled design. Across these studies, 348 individuals with non-rapid eye movement parasomnias were described, with 148 receiving treatments with hypnosis. A positive clinical response was reported in approximately 82.6 % of these treated cases. However, the overall quality of evidence was low, with most studies offering limited methodological robustness and lacking standardized outcome measures. The hypnotic induction and suggestion techniques varied widely, yet general suggestions aimed at improving sleep quality were more frequently reported than specific ones targeting parasomnia features. Nevertheless, the more specific suggestions seemed to have better outcomes. This review suggests that hypnosis could be a promising therapeutic option. However, further, well-designed trials are required, including objective outcome evaluation, and standardized, targeted hypnotic approaches developed collaboratively between sleep and hypnosis specialists.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102227"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145883593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}